Thioctic acid
Japan Standards for Cosmetics: Thioctic acid
The provisional English translation of the MHLW Standards for Cosmetics lists this ingredient with the stated limit or use matrix.
监管决定及完整条件
- 状态
- Restricted
- 法律地位
- Binding rule
- 监管摘要
- The provisional English translation of the MHLW Standards for Cosmetics lists this ingredient with the stated limit or use matrix.
- 条件与限制
Published three-column use matrix (rinse-off / leave-on / mucosal; blank means prohibited, ○ means no upper limit): 0.01 0.01
物质身份
- 官方来源名称
- Thioctic acid
- CAS
- 1077-28-7
- EC
- 214-071-2
- 身份映射
- exact INCI name
- 关联成分
- THIOCTIC ACID
关联的 CosIng 身份数据
名称和别名
CosIng 描述: 1,2-Dithiolane-3-pentanoic acid, (+/-)-
已记录的化妆品功能: ANTIOXIDANT
功能页面:ANTIOXIDANT
查看完整的成分档案该身份的跨市场概览
本站目前已有的精确关联记录。某市场缺失表示没有已导入的精确匹配,并不表示准许使用该物质。
Japan
当前记录1 条关联记录 · 1 条含特定条件
打开支持记录
CAS 1077-28-7 的已核实化学信息
alpha Lipoic acid
Lipoic acid is a heterocyclic thia fatty acid comprising pentanoic acid with a 1,2-dithiolan-3-yl group at the 5-position. It has a role as a geroprotector and a fundamental metabolite. It is a member of dithiolanes, a heterocyclic fatty acid and a thia fatty acid. It is functionally related to an octanoic acid. It is a conjugate acid of a lipoate. — ChEBI
- IUPAC 名称
- 5-(dithiolan-3-yl)pentanoic acid
- 分子式
- C8H14O2S2
- 分子量
- 206.3 g/mol
- 精确质量
- 206.04352203 Da
- 单同位素质量
- 206.04352203 Da
- XLogP3
- 1.7
- 拓扑极性表面积
- 87.9 Ų
- 分子复杂度
- 150.0
- 形式电荷
- 0
- 氢键供体
- 1
- 氢键受体
- 4
- 可旋转键
- 5
- 重原子
- 12
- 共价单元
- 1
向 PubChem 报告的名称和同义词
另有 16 个已报告名称
外部数据库标识符
- ChEBI:CHEBI:16494
- ChEMBL:CHEMBL33864
- EPA DTXSID:DTXSID7025508
- PubMed:22654724
- PubMed:22448096
- PubMed:22384101
- PubMed:22374556
- PubMed:22363901
- PubMed:22272085
- PubMed:22242957
- PubMed:22163871
- PubMed:22163517
- PubMed:22146387
- PubMed:22125679
- PubMed:22125537
高级结构统计
- 已定义的原子立体中心
- 0
- 未定义的原子立体中心
- 1
- 已定义的键立体中心
- 0
- 未定义的键立体中心
- 0
- 三维药效团特征
- 5
- 三维环
- 1
- 三维疏水基团
- 1
- 三维受体特征
- 2
- 三维供体特征
- 0
- 三维阴离子中心
- 1
- 三维阳离子中心
- 0
- 三维构象异构体
- 10
- 有效三维可旋转键
- 6.0
机器可读的结构标识符
- SMILES
C1CSSC1CCCCC(=O)O- InChI
InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)- InChIKey
AGBQKNBQESQNJD-UHFFFAOYSA-N
来自其他科学数据库的证据
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Color/Form: Forms yellowish flakes 来源: Hazardous Substances Data Bank (HSDB)
- Dissociation Constants: pKa = 5.10 来源: Hazardous Substances Data Bank (HSDB)
- Melting Point: 47.5-48 °C 来源: Hazardous Substances Data Bank (HSDB)
- Solubility: Yellow powder; solubility in ethanol: 50 mg/mL /Synthetic, oxidized form/ 来源: Hazardous Substances Data Bank (HSDB)
- Solubility: Soluble in methanol, ethanol, diethyl ether and chloroform 来源: Hazardous Substances Data Bank (HSDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). 来源: Toxin and Toxin Target Database (T3DB)
- Note: This chemical does not meet GHS hazard criteria for 6.5% (28 of 430) of reports. 来源: European Chemicals Agency (ECHA)
- Signal: Warning 来源: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (93.5%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (48.6%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (46.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (47%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H411 (46.5%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] 来源: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P261, P264, P264+P265, P270, P272, P273, P280, P301+P317, P302+P352, P305+P351+P338, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P391, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 430 reports by companies from 16 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 28 of 430 reports by companies.; There are 14 notifications provided by 402 of 430 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
- Note: This chemical does not meet GHS hazard criteria for 42.3% (52 of 123) of reports. 来源: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (57.7%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (31.7%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (31.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (31.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H412 (19.5%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] 来源: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 123 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 52 of 123 reports by companies.; There are 7 notifications provided by 71 of 123 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
- Health Effects: Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, incre 来源: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: ALA is generally considered a safe drug. A daily dose of 200 mg/day to 2400 mg/day of ALA is deemed safe without significant adverse effects. However, there is no reported safe dose in children.; A notable case in literature demonstrated status epilepticus (SE) that subsided within a few days. The seizures were treated per normal standards for SE.; In the last 2 decades, there have been few reported cases of ALA toxicity in humans. Most of these cases occur in children and are treatable. Though there is no established lethal dosage of ALA for humans, studies have shown that a high dose of 121 mg/kg body weight/day was associated with alterations in liver enzymes and liver function. Therefore, there are potentially harmful adverse effects from overdosing on ALA, and more studies are necessary to determine the toxicity. 来源: StatPearls
- Toxicity Summary: (R)-lipoic acid is a cholinesterase or acetylcholinesterase (AChE) inhibitor. A cholinesterase inhibitor (or 'anticholinesterase') suppresses the action of acetylcholinesterase. Because of its essential function, chemicals that interfere with the action of acetylcholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death. Nerve gases and many substances used in insecticides have been shown to act by binding a serine in the active site of acetylcholine esterase, inhibiting the enzyme completely. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop. Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as 来源: Toxin and Toxin Target Database (T3DB)
- Uses: Nutrition, biochemical research /Thioctic acid, dl-form/ 来源: Hazardous Substances Data Bank (HSDB)
- Uses: THERAPEUTIC CATEGORY: Treatment of liver disease; antidote to poisonous mushrooms (Amanita species). 来源: Hazardous Substances Data Bank (HSDB)
- Uses: Use (kg; approx.) in Germany (2009): >7500; Consumption (g per capita; approx.) in Germany (2009): 0.0916; Calculated removal (%): 96.4 来源: NORMAN Suspect List Exchange
- Uses: For nutritional supplementation, also for treating dietary shortage or imbalance. 来源: Toxin and Toxin Target Database (T3DB)
映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录
科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。
其他来源的覆盖范围和匹配状态
| 来源 | 结果 | 已检查 |
|---|---|---|
| NIH PubChem PUG-View | 精确匹配 | 2026-08-31 |
已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。
于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与出处
- 已登记来源
- Japan MHLW Standards for Cosmetics
- 来源参考
- Appendix 2 section 3, entry 2
- 来源记录 ID
appendix-2-3:2- 来源版本
- MHLW Notification No. 331 provisional translation, retrieved 2026-08-30
- 来源语言
- English provisional translation; Japanese text is canonical
- 翻译状态
- Regulator-hosted provisional English translation · 英文译文
- 快照检查时间
- 2026-08-30 04:11 UTC
- 验证方法
- pdftotext -layout plus strict per-table row counts
- SHA-256
117fc949a82789ca66017163f19041cf2fcf6b5902708077c8e4f56c482dc8e2
已登记的数据集备注
- 数据集覆盖范围
- Prohibited and restricted ingredient appendices with concentration and use conditions
- 权威性说明
- Official MHLW standard; validate later Japanese updates before presenting current status
本记录在市场数据集中的位置
Japan 市场背景
Complete Standards appendices dataset
覆盖版本: MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
Prohibited ingredients, restricted ingredients and permitted preservative/UV/colourant appendices present in the official standard source.
核实清单
- Search Japanese/English identity and CAS where present.
- Apply category and maximum-amount conditions.
- Check later MHLW notices against the Japanese source.
- Verify marketing licence, notification, labelling and quasi-drug classification.
官方市场来源
- Japan MHLW Standards for CosmeticsOfficial MHLW standard; validate later Japanese updates before presenting current status
核实工作流程与记录完整性
在将此结果用于合规决定之前
- 确认“Thioctic acid”及每个 CAS/EC 标识符所指的物料与您的供应商规格一致。
- Search Japanese/English identity and CAS where present.
- Apply category and maximum-amount conditions.
- Check later MHLW notices against the Japanese source.
- Verify marketing licence, notification, labelling and quasi-drug classification.
- 记录来源版本,并在生产、备案或上市之前重新核查监管机构。
本记录中的可用字段
- 官方物质名称可用
- CAS可用
- EC可用
- 单独的条件文本可用
- 生效日期未提供
- 快照哈希与方法可用
本页回答的问题
稳定引用
Thioctic acid. Appendix 2 section 3, entry 2. Japan. Source version MHLW Notification No. 331 provisional translation, retrieved 2026-08-30. CosIng Checker regulatory record: https://cosingchecker.com/zh-hans/regulations/jp/records/633/
请将监管机构作为法律依据来引用。本页是结构化的证据索引和核实辅助工具,不能替代官方文本或专业法律评估。
Japan 的解读与局限
This substance is not unrestricted: cosmetic use is subject to the conditions in the cited official record.
Check product type, body area, concentration, purity and warning requirements before deciding whether a formulation is compliant.
如何解读法律地位
The cited row forms part of a binding rule or legally incorporated list for this market.
本页证据
- 记录结果:Restricted
- 法律地位:Binding rule
- 来源版本:MHLW Notification No. 331 provisional translation, retrieved 2026-08-30
它不能证明什么
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
进一步的权威物质研究
这些来源均不能推翻上述市场决定。
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
在来源处研究此身份FDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
在来源处研究此身份ILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
在来源处研究此身份Japan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
在来源处研究此身份NIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
在来源处研究此身份OECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
在来源处研究此身份US EPA CompTox CTX APIs
导入需要 API 密钥DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
在来源处研究此身份